Literature DB >> 7304394

Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation.

S B Olsson, N Edvardsson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7304394     DOI: 10.1016/0002-8703(81)90037-5

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  16 in total

1.  Pharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs.

Authors:  Dan M Roden
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

Review 2.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

3.  Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervals.

Authors:  B Darpö; O Almgren; R Bergstrand; S Franzén; N Edvardsson
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 4.  Safety of flecainide.

Authors:  Juan Tamargo; Alessandro Capucci; Philippe Mabo
Journal:  Drug Saf       Date:  2012-04-01       Impact factor: 5.606

5.  Effects of disopyramide on repolarisation and intraventricular conduction in man.

Authors:  K Endresen; J P Amlie; K Forfang
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Evaluation of drug-induced changes in myocardial repolarisation using the paced evoked response.

Authors:  R M Donaldson; A F Rickards
Journal:  Br Heart J       Date:  1982-10

7.  Ventricular and atrial electrophysiological effects of a IC antiarrhythmic drug, cibenzoline, in the innervated dog heart. Role of sodium and calcium channels.

Authors:  Q Timour; J F Aupetit; J Loufoua-Moundanga; L Bertrix; M Freysz; G Faucon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

8.  Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.

Authors:  K J Hellestrand; R S Bexton; A W Nathan; R A Spurrell; A J Camm
Journal:  Br Heart J       Date:  1982-08

9.  The haemodynamic effect of intravenous flecainide acetate in patients with coronary artery disease.

Authors:  P W Serruys; G Vanhaleweyk; M Van Den Brand; P Verdouw; J Lubsen; P G Hugenholtz
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

10.  Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.

Authors:  A J Camm; K J Hellestrand; A W Nathan; R S Bexton
Journal:  Drugs       Date:  1985       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.